Sinha, Rajiv <br/><br/>
Should gonadotropin releasing hormone analogue be administered to prevent premature ovarian failure in young women with systemic lupus erythematosus on cyclophosphamide therapy?  [electronic resource] 

 -  Archives of disease in childhood  May 2008 
 - 444-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1468-2044 
<br/><br/><label>Standard No.: </label>10.1136/adc.2007.131334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--complications<br/>Adolescent<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Cyclophosphamide--adverse effects<br/>Female<br/>Gonadotropin-Releasing Hormone--therapeutic use<br/>Humans<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Primary Ovarian Insufficiency--chemically induced